In the last two decades, disorders of the p53 tumor suppressor gene have been correlated with ccRCC insurgence, with presence of p53 mutants in neoplastic tissues frequently associated with reduced or null responsiveness to treatment5, 6, 7. The gene discussed is TP53; the disease is nonpapillary renal cell carcinoma.